SEC 13F Intelligence

Bain Capital Life Sciences Investors, LLC / REPL

Bain Capital Life Sciences Investors, LLC’s Replimune Group Inc Position

Does Bain Capital Life Sciences Investors, LLC own Replimune Group Inc (REPL)? Not currently — the last reported position was 2.12M shares worth $49M in Q3 2020; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$49M
Q3 2020
Shares
2.12M
% of Portfolio
+4.55%
Quarters Held
8
position exited

Position History REPL

Reported value by quarter
Q4 ’18: $28MQ4 ’18Q1 ’19: $43MQ1 ’19Q2 ’19: $42MQ2 ’19Q3 ’19: $39MQ3 ’19Q4 ’19: $41MQ4 ’19Q1 ’20: $28MQ1 ’20Q2 ’20: $54MQ2 ’20Q3 ’20: $49MQ3 ’20filingsflow.com
QuarterSharesValue% of Portfolio
Q3 20202.12M$49M+4.55%
Q2 20202.16M$54M+5.63%
Q1 20202.84M$28M+4.79%
Q4 20192.84M$41M+6.08%
Q3 20192.84M$39M+10.16%
Q2 20192.84M$42M+21.14%
Q1 20192.84M$43M+17.28%
Q4 20182.84M$28M+9.70%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Bain Capital Life Sciences Investors, LLC’s full portfolio or all institutional holders of REPL.